相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies
Susumu Goyama et al.
CANCER SCIENCE (2009)
High EVI1 levels predict adverse outcome in acute myeloid leukemia:: prevalence of EVI1 overexpression. and chromosome 3q26 abnormalities underestimated
Sanne Lugthart et al.
BLOOD (2008)
AML1 mutations induced MDS and MDS/AML in a mouse BMT model
Naoko Watanabe-Okochi et al.
BLOOD (2008)
Significant increase of self-renewal in hematopoietic cells after forced expression of EVI1
Leopoldo Laricchia-Robbio et al.
BLOOD CELLS MOLECULES AND DISEASES (2008)
Evi-1 promotes para-aortic splanchnopleural hematopoiesis through up-regulation of GATA-2 and repression of TGF-β signaling
Tomohiko Sato et al.
CANCER SCIENCE (2008)
Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells
Susumu Goyama et al.
CELL STEM CELL (2008)
A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a
Dominik Spensberger et al.
FEBS LETTERS (2008)
EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression
Francesca Cattaneo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1
M. Takeshita et al.
LEUKEMIA (2008)
Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis
Guang Jin et al.
BLOOD (2007)
Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase
Stefan Kubicek et al.
MOLECULAR CELL (2007)
Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP
E Nitta et al.
ONCOGENE (2005)
Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9
D Greiner et al.
NATURE CHEMICAL BIOLOGY (2005)
Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression
H Yuasa et al.
EMBO JOURNAL (2005)
Prognostically useful gene-expression profiles in acute myeloid leukemia
PJM Valk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing
I Gyory et al.
NATURE IMMUNOLOGY (2004)
EVI1 induces myelodysplastic syndrome in mice
S Buonamici et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Partitioning and plasticity of repressive histone methylation states in mammalian chromatin
AHFM Peters et al.
MOLECULAR CELL (2003)
Retrovirus-mediated gene transfer and expression cloning: Powerful tools in functional genornics
T Kitamura et al.
EXPERIMENTAL HEMATOLOGY (2003)
Transformation of bone marrow B-cell progenitors by E2A-HLF requires coexpression of BCL-2
KS Smith et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles
S Chakraborty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase
U Vinatzer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Evi-1 transforming and repressor activities are mediated by CtBP Co-repressor proteins
S Palmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
SET domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3
M Tachibana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The corepressor CtBP interacts with Evi-1 to repress transforming growth factor β signaling
K Izutsu et al.
BLOOD (2001)
Regulation of chromatin structure by site-specific histone H3 methyltransferases
S Rea et al.
NATURE (2000)
The Evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death
M Kurokawa et al.
EMBO JOURNAL (2000)